Published in Int J Colorectal Dis on June 14, 2008
Long-term success rate after surgical treatment of anorectal and rectovaginal fistulas in Crohn's disease. Int J Colorectal Dis (2009) 0.89
Inflammatory bowel disease: perioperative pharmacological considerations. Mayo Clin Proc (2011) 0.82
Therapy of complicated Crohn's disease during pregnancy--an interdisciplinary challenge. Int J Colorectal Dis (2014) 0.76
Infliximab for the treatment of fistulas in patients with Crohn's disease. N Engl J Med (1999) 6.24
Serious infections and mortality in association with therapies for Crohn's disease: TREAT registry. Clin Gastroenterol Hepatol (2006) 4.18
Efficacy and safety of retreatment with anti-tumor necrosis factor antibody (infliximab) to maintain remission in Crohn's disease. Gastroenterology (1999) 2.62
Tumor necrosis factor alpha antibody (infliximab) therapy profoundly down-regulates the inflammation in Crohn's ileocolitis. Gastroenterology (1999) 2.46
Clinical experience with infliximab therapy in 100 patients with Crohn's disease. Am J Gastroenterol (2000) 1.79
Endoanal advancement flap repair for complex anorectal fistulas. Am J Surg (1999) 1.64
Successful management of Crohn's disease of the ileoanal pouch with infliximab. Gastroenterology (1999) 1.56
Magnetic resonance imaging of the effects of infliximab on perianal fistulizing Crohn's disease. Am J Gastroenterol (2003) 1.55
Clinical and radiological responses after infliximab treatment for perianal fistulizing Crohn's disease. Am J Gastroenterol (2004) 1.53
[Suspected cases of severe side effects after infliximab (Remicade) in Germany]. Med Klin (Munich) (2003) 1.38
Natural history of perianal Crohn's disease. Ten year follow-up: a plea for conservatism. Am J Surg (1980) 1.22
Current status and influence of operation on perianal Crohn's disease. Int J Colorectal Dis (1986) 1.16
Review article: safety of infliximab in clinical trials. Aliment Pharmacol Ther (1999) 1.12
Perianal Crohn's disease. Results of local surgical treatment. Dis Colon Rectum (1996) 1.12
Treatment of perianal fistulizing Crohn's disease with infliximab alone or as an adjunct to exam under anesthesia with seton placement. Inflamm Bowel Dis (2003) 1.11
Anal fissure in Crohn's disease: a plea for aggressive management. Dis Colon Rectum (1995) 1.08
Treatment of fistulizing Crohn's disease. Gastroenterology (2000) 1.05
Combined seton placement, infliximab infusion, and maintenance immunosuppressives improve healing rate in fistulizing anorectal Crohn's disease: a single center experience. Dis Colon Rectum (2003) 1.03
A critical assessment of new therapies in inflammatory bowel disease. J Gastroenterol Hepatol (2002) 1.01
Fistulating anal Crohn's disease: results of combined surgical and infliximab treatment. Dis Colon Rectum (2006) 1.01
Staged mucosal advancement flap for the treatment of complex anal fistulas: pretreatment with noncutting Setons and in case of recurrent multiple abscesses a diverting stoma. Colorectal Dis (2005) 1.00
Surgical approaches to low anovaginal fistula in Crohn's disease. Am J Surg (1997) 0.95
Infliximab in the surgical management of complex fistulating anal Crohn's disease. Colorectal Dis (2005) 0.94
Endosonographic evidence of persistence of Crohn's disease-associated fistulas after infliximab treatment, irrespective of clinical response. Dis Colon Rectum (2002) 0.94
Efficacy and safety of repeated infliximab infusions for Crohn's disease: 1-year clinical experience. Inflamm Bowel Dis (2001) 0.91
Perianal fistulae following infliximab treatment: clinical and endosonographic outcome. Inflamm Bowel Dis (2004) 0.91
Successful treatment of refractory esophageal Crohn's disease with infliximab. Dig Dis Sci (2001) 0.89
Safety of biologic therapy. Inflamm Bowel Dis (2007) 0.89
Long-term durability of Crohn's disease treatment with infliximab. Dig Dis Sci (2007) 0.88
Response of fistulating Crohn's disease to infliximab treatment assessed by magnetic resonance imaging. Aliment Pharmacol Ther (2003) 0.88
Rapid response of severe refractory metastatic Crohn's disease to infliximab. J Gastroenterol Hepatol (2001) 0.88
Twenty-year review of the surgical management of perianal Crohn's disease. Dis Colon Rectum (1995) 0.87
Factors related to frequency, type, and outcome of anal fistulas in Crohn's disease. Dis Colon Rectum (1995) 0.87
Advancement sleeve flaps for treatment of severe perianal Crohn's disease. Br J Surg (1998) 0.87
Surgical treatment of anorectal complications in Crohn's disease. Surgery (2000) 0.86
Island flap anoplasty for treatment of transsphincteric fistula-in-ano. Dis Colon Rectum (1996) 0.85
Advancement flap plasty for the closure of anal and recto-vaginal fistulas in Crohn's disease. Acta Gastroenterol Belg (2001) 0.83
Anti-TNF-alpha (infliximab) used as induction treatment in case of active proctitis in a multistep strategy followed by definitive surgery of complex anal fistulas in Crohn's disease: a preliminary report. Dis Colon Rectum (2005) 0.83
Use of infliximab in pediatric patients with inflammatory bowel disease. Ann Pharmacother (2001) 0.82
Maintenance of remission with infliximab in inflammatory bowel disease: efficacy and safety long-term follow-up. World J Gastroenterol (2007) 0.81
Prevention of postoperative recurrence of Crohn's disease by infliximab. Eur J Gastroenterol Hepatol (2006) 0.81
Efficacy of infliximab in Crohn's disease. Results of a retrospective multicenter study with a 15-month follow-up. Gastroenterol Clin Biol (2006) 0.77
[Surgical treatment of high anorectal and rectovaginal fistulas with the use of transanal endorectal advancement flaps]. Chirurg (2000) 0.77
[Anodermal advancement flap-plasty as alternative treatment method to endorectal closure techniques in therapy of high anal fistulas. A prospective study of 31 patients]. Chirurg (1996) 0.76
Definitive repair of anovaginal fistula in Crohn's disease. Ann R Coll Surg Engl (1998) 0.76
[Results with a new therapy concept in anal fistula: suture of the anal sphincter]. Schweiz Med Wochenschr (1996) 0.75
[Anorectal fistulas in Crohn disease]. Zentralbl Chir (1999) 0.75
A girl with severe fistulizing Crohn's disease. Dig Liver Dis (2000) 0.75
Management of perianal Crohn's disease. Can J Gastroenterol (2000) 0.75
Surgical treatment of inflammatory bowel disease. Curr Opin Gastroenterol (1999) 0.75
[Inflammatory bowel diseases (Crohn disease and ulcerative colitis). Possibilities and limitations of surgical therapy]. Ther Umsch (1991) 0.75
Reciprocal IFN-gamma and TGF-beta responses regulate the occurrence of mucosal inflammation. Immunol Today (1997) 2.52
Anti-interleukin 12 treatment regulates apoptosis of Th1 T cells in experimental colitis in mice. Gastroenterology (1999) 2.15
Factors involved in the differentiation of TGF-beta-producing cells from naive CD4+ T cells: IL-4 and IFN-gamma have opposing effects, while TGF-beta positively regulates its own production. J Immunol (1998) 1.56
Oral tolerance. J Clin Immunol (1998) 1.11
An evaluation of antimicrobial treatment for Whipple's Disease. Tetracycline versus trimethoprim-sulfamethoxazole. Dig Dis Sci (1994) 1.02
Treatment of refractory Whipple disease with interferon-gamma. Ann Intern Med (1998) 0.93
[S2k-guideline gastrointestinal infectious diseases and Whipple's disease]. Z Gastroenterol (2015) 0.85
Limited role for PCR-based diagnosis of Whipple's disease from peripheral blood mononuclear cells. Lancet (1996) 0.85
Decreased levels of interleukin-12p40 in the serum of patients with Whipple's disease. Int J Colorectal Dis (2005) 0.84
-295 T-to-C promoter region IL-16 gene polymorphism is associated with Whipple's disease. Eur J Clin Microbiol Infect Dis (2015) 0.84
Cytokine genetic profile in Whipple's disease. Eur J Clin Microbiol Infect Dis (2012) 0.81
Increased expression of interleukin-12 receptor beta(2) on lamina propria mononuclear cells of patients with active Crohn's disease. Int J Colorectal Dis (2002) 0.79
Interleukin-18 is increased only in a minority of patients with active Crohn's disease. Int J Colorectal Dis (2007) 0.77
Non-alcoholic steatohepatitis occurs in celiac disease and is associated with cellular stress. Z Gastroenterol (2013) 0.76
Progress, problems, and perspectives in diagnosis and treatment of Whipple's disease. Clin Exp Med (2004) 0.76
[Anti-inflammatory properties of interleukin-10 in human Crohn's disease: much to learn, much to explore]. Z Gastroenterol (2002) 0.75
Cutaneous anergy to streptococcal antigens in Whipple's disease. Am J Gastroenterol (1996) 0.75
[Lymphocytes induce transformation of enterocytes into antigen-transporting M cells]. Z Gastroenterol (1998) 0.75
Current concepts of immunopathogenesis, diagnosis and therapy in Whipple's disease. Curr Med Chem (2006) 0.75
[Disorders of apoptosis in chronic inflammatory bowel diseases]. Z Gastroenterol (2000) 0.75
[Whipple disease. Formerly dim prognosis--often treatable today]. MMW Fortschr Med (2002) 0.75